Physician profile
Michael D Kent
NPI 1871585364
$8,019.70
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.74 · 2021: $14.18 · 2022: $120 · 2023: $439 · 2024: $7,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Travel and Lodging: $2,140 · Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Travel and Lodging | $2,140.38 |
| Food and Beverage | $1,187.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $5,212.51 | 2022-2024 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $2,442.64 | 2024 | Arcos, Persona, Rosa |
| Heron Therapeutics, INC. | $109.97 | 2023 | Zynrelef |
| Innovation Technologies INC | $109.78 | 2023 | Irrisept |
| Medinc of Texas | $72.88 | 2023 | |
| Pacira Therapeutics, INC. | $32.66 | 2019 | |
| Abbott Laboratories | $19.85 | 2019 | |
| Smith+Nephew, INC. | $14.18 | 2021 | |
| Wound Management Technologies, INC | $5.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.